Cavernous sinus thrombosis interventions

Jump to navigation Jump to search

Cavernous sinus thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cavernous sinus thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous sinus thrombosis interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous sinus thrombosis interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous sinus thrombosis interventions

CDC on Cavernous sinus thrombosis interventions

Cavernous sinus thrombosis interventions in the news

Blogs on Cavernous sinus thrombosis interventions

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cavernous sinus thrombosis interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Early endovascular therapy may help preserve vision in patients in patients with acute cavernous sinus thrombosis. Combination of medical and surgical interventions may be in management of cavernous sinus thrombosis. Endovascular therapy of cerebral venous thrombosis using approaches to intracranial recanalization include: Thrombolysis and thrombectomy. This interventions are not well described and there are few studies about this interventions. Successful recanalization of the bilateral cavernous sinuses and superior ophthalmic veins was achieved in some studies without complication.

Intervention

Early endovascular therapy may help preserve vision in patients in patients with acute cavernous sinus thrombosis.[1][2][3]

Combination of medical and surgical interventions may be in management of cavernous sinus thrombosis.[2][4]

Endovascular therapy of cerebral venous thrombosis using approaches to intracranial recanalization include:[1][2][4]

This interventions are not well described and there are few studies about this interventions.[3][5]

Successful recanalization of the bilateral cavernous sinuses and superior ophthalmic veins was achieved in some studies without complication.[1][2]

References

  1. 1.0 1.1 1.2 Bauer J, Kansagra K, Chao KH, Feng L (2018). "Transfemoral thrombectomy in the cavernous sinus and superior ophthalmic vein". BMJ Case Rep. 2018. doi:10.1136/bcr-2017-013571. PMID 29437716.
  2. 2.0 2.1 2.2 2.3 Khan SH, Adeoye O, Abruzzo TA, Shutter LA, Ringer AJ (2009). "Intracranial dural sinus thrombosis: novel use of a mechanical thrombectomy catheter and review of management strategies". Clin Med Res. 7 (4): 157–65. doi:10.3121/cmr.2009.847. PMC 2801689. PMID 20048139.
  3. 3.0 3.1 Mascitelli JR, Pain M, Zarzour HK, Baxter P, Ghatan S, Mocco J (2015). "Sinus thrombectomy for purulent cerebral venous sinus thrombosis utilizing a novel combination of the Trevo stent retriever and the Penumbra ACE aspiration catheter: the stent anchor with mobile aspiration technique". BMJ Case Rep. 2015. doi:10.1136/bcr-2015-011782. PMC 4442185. PMID 26002667.
  4. 4.0 4.1 Desa V, Green R (2012). "Cavernous sinus thrombosis: current therapy". J Oral Maxillofac Surg. 70 (9): 2085–91. doi:10.1016/j.joms.2011.09.048. PMID 22326173.
  5. Konakondla S, Schirmer CM, Li F, Geng X, Ding Y (2017). "New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments". Aging Dis. 8 (2): 136–148. doi:10.14336/AD.2016.0915. PMC 5362174. PMID 28400981.

Template:WH Template:WS